These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 14416174)
1. Tumour specificity and immunological suppression. LEVI E; SCHECHTMAN AM; SHERINS RS; TOBIAS S Nature; 1959 Aug; 184(Suppl 8)():563-5. PubMed ID: 14416174 [No Abstract] [Full Text] [Related]
2. Further observations on tumour-enhancing factors: their bearing on the immunological theory of cancer. GREEN HN; WILSON R Nature; 1958 Oct; 182(4642):1054-8. PubMed ID: 13590225 [No Abstract] [Full Text] [Related]
3. [Production of anti-cancer sera of narrow specificity]. NAZARENKO NA Vopr Onkol; 1960; 6(3)():14-8. PubMed ID: 14426259 [No Abstract] [Full Text] [Related]
4. Immunological discrimination between the blood of normal and of tumour-bearing rats. DARCY DA Nature; 1955 Oct; 176(4483):643-4. PubMed ID: 13265796 [No Abstract] [Full Text] [Related]
5. [Quantitative characteristics of anti-cancer gamma-globulins of a narrow specificity]. NAZARENKO NA Biull Eksp Biol Med; 1962 Feb; 53():75-8. PubMed ID: 14478669 [No Abstract] [Full Text] [Related]
7. IMMUNOLOGICAL tolerance in tumour studies; adaptation of ascites tumours to homologous or heterologous hosts; discussion. Proc R Soc Lond B Biol Sci; 1956 Nov; 146(922):57-8. PubMed ID: 13379351 [No Abstract] [Full Text] [Related]
8. Effect of immunological attenuation on cell dosage required to establish single or double tumour homografts. VAN DEN BRENK HA Br J Cancer; 1961 Dec; 15(4):798-803. PubMed ID: 13924532 [No Abstract] [Full Text] [Related]
9. Specificity and effects of antibodies that react with antigens of cancer cells: examples and derivative observations. KIDD JG Acta Unio Int Contra Cancrum; 1959; 15():921-3. PubMed ID: 14408955 [No Abstract] [Full Text] [Related]
10. [On the specificity of antigens found in the blood plasma of rabbits with Brown-Pearce carcinoma]. SHEVALIAGIN VIa Vopr Onkol; 1959; 5():149-53. PubMed ID: 14445931 [No Abstract] [Full Text] [Related]
11. [Immunology and immunotherapy of malignant tumors: balance and prospects 1978]. Nagel GA Schweiz Med Wochenschr; 1978 Aug; 108(32):1228-32. PubMed ID: 307815 [TBL] [Abstract][Full Text] [Related]
12. Tumour suppression by immune system through stochastic oscillations. Caravagna G; d'Onofrio A; Milazzo P; Barbuti R J Theor Biol; 2010 Aug; 265(3):336-45. PubMed ID: 20580640 [TBL] [Abstract][Full Text] [Related]
13. Immunological markers that predict radiation toxicity. Sprung CN; Forrester HB; Siva S; Martin OA Cancer Lett; 2015 Nov; 368(2):191-7. PubMed ID: 25681035 [TBL] [Abstract][Full Text] [Related]
15. THE GROWTH AND INFILTRATION OF EHRLICH'S ASCITES TUMOUR IN MICE WITH REDUCED IMMUNOLOGICAL RESPONSES. WHEATLEY DN; EASTY GC Br J Cancer; 1964 Dec; 18(4):743-55. PubMed ID: 14264940 [No Abstract] [Full Text] [Related]
16. Modeling Tumor Immunology and Immunotherapy in Mice. Buqué A; Galluzzi L Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876 [TBL] [Abstract][Full Text] [Related]
17. Progress in human tumour immunology and immunotherapy. Rosenberg SA Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146 [TBL] [Abstract][Full Text] [Related]
18. The phenomenon of immunological enhancement, with special reference to immunological tolerance. BRENT L Cancro; 1961; 14():507-27. PubMed ID: 13872844 [No Abstract] [Full Text] [Related]